T:Slim Insulin Monitor & Pump by Tandem Diabetes Care is a smart and easy way to manage insulin and Diabetes. It utilizes a unique pumping mechanism and has a smooth, compact design.This feature allows the insulin care system to be easily slipped into a pocket or worn discreetly under clothing. The Insulin Pump system is easy to use with a smart phone-style interface and touch screen technology. Its Micro-Delivery technology contributes to its small size and delivers insulin in the tiniest increments available.
T Slim Insulin Pump Monitor has a built-in rechargeable battery that uses the latest in lithium-polymer rechargeable technology. It can pack a 300-unit reservoir that is good for up to seven days of power. The integrated micro-USB on the insulin pump system allows for convenient charging and fast data transfer speeds. It comes with a Diabetes Management Application, which is state-of-the-art PC and Mac compatible data management software. The touch screen for the pump system is made of high-grade, shatter-resistant glass. It has an aluminum case that makes it durable and light.The pump system is also watertight, so you don't have to worry about it getting wet.
t-slim Insulin Pump System by Tandem Diabetes Care measures 2" x 3.13" x .6". It includes a 4-year warranty and a 24-hour Product Replacement Program.
T:Slim Insulin Pump Features and Benefits
Provides continuous glucose monitoring.
Unique pumping mechanism.
Smooth, compact design.
Easily slip into pocket or wear discreetly under clothing.
Easy to use menu navigation.
Smart, phone-style interface.
Touch screen technology.
Delivers insulin in tiniest increments available.
Aluminum case makes it durable and light.
Watertight for up to 3 feet for 30 minutes.
Convenient and easy glucose sensor insertion.
Rechargeable battery good for up to seven days.
Six customizable profiles for insulin delivery settings.
16 timed settings per personal profile.
T:Slim Insulin Monitor Specifications
TSlim Insulin Monitor and Pump Product Number: TN004629.
Insulin Duration: 2-8 hours in 1-minute increments.
Bolus Options: Standard Bolus, Correction Bolus, Extended Bolus and Quick-Bolus.
Bolus Increments: 0.01 unit (at volumes greater than 0.05 units)
Insulin Sensitivity Factors: 1:1 to 1:600 mg/dL (1 mg/dL increments)
Insulin to Carb Ratio: 1:1 to 1:300 g (0.1 increments below 10 grams)
Maximum Bolus Size: 25 units (with an option for an additional 25 units)
Basal Insulin Delivery: 0.001 units at programmed rates ≥ units/hour.
Maximum Basal Deliver: 15 units/hour.
Temporary Basal Rate: 15 minutes to 72 hours (range of 0 to 250%).
Diabetes management application is PC and Mac compatible.
24-hour Product Replacement Program.
Power Requirements: Battery.
Battery: Rechargeable lithium polymer battery.
Infusion Sets: Standard luer-lock.
HCPCS Code: E0784,
Warranty: 4 Years.
T Slim Insulin Monitor Additional Information
Bode BW, Gross K, Rikalo N, et al. Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous glucose monitoring system. Diabetes Technol Ther. 2004;6(2):105-113.
Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.JAMA. 1997;277(5):374-375.
Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study.Pediatrics. 2003;111(5 Pt 1):933-938. Derr R, Garrett E, Stacy G, et al.
Is HbA1C affected by glycemic instability? Diabetes Care. 2003;26(10):2728-2733.
Gross TM, Kayne D, King A, et al. A bolus calculator is an effective means of controlling postprandial glycemia in patients on insulin pump therapy. Diabetes Technol Ther.2003;5(3):365-369.
Kaufman FR, Gibson LC, Halvorson M, et al. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care. 2001;24(12):2030-2034.
Bode BW, Gross TM, Thornton KR, et al. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract. 1999;46:183-190.